Pharma Journalist -

Regeneron Pharmaceuticals and Sanofi announced that the U.S. Food and Drug Administration (FDA) has approved Praluent (alirocumab) to reduce the risk of heart attack, stroke and…
Read More...

Lonza announced the global availability of the world’s first fully automated and integrated plate-based PyroTec PRO Robotic Solution for endotoxin testing. Combining the speed and…
Read More...

Gilead Sciences announced that STELLAR-3, a Phase 3, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of selonsertib, an investigational, once…
Read More...

ACADIA Pharmaceuticals Inc. announced the initiation of the Phase 3 CLARITY-2 study and plans to initiate the Phase 3 CLARITY-3 study in the upcoming months. These studies will evaluate…
Read More...

Salix Pharmaceuticals and a wholly owned subsidiary of Bausch Health Companies Inc. announced that its affiliate has entered into an exclusive licensing agreement with Mitsubishi Tanabe…
Read More...

Hear from Amgen as they will be presenting the Keynote Address: Platform approach for combination products and devices on day one by Ronald Forster, Executive Director, Amgen and Kesley…
Read More...

Biotheque Wallonie Bruxelles to lead a workshop at the 9th Annual Biobanking Conference SMi Group are delighted to have the industry expert Laurent Dolle, Managing Director,…
Read More...

Highly Potent APIs 2019 Conference: Interview with Bayer Pharma Dr Ulrich Rüemenapp, Head of Launch Preparation and Coordination at Bayer Pharma, will be discussing late stage CMC…
Read More...

Forge Therapeutics, Inc. (Forge) and Basilea Pharmaceutica International Ltd. (Basilea), a wholly-owned subsidiary of Basilea Pharmaceutica Ltd., announced that they have entered into a…
Read More...

La Jolla Pharmaceutical Company announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for the New Investigational Drug Product,…
Read More...